IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

New Leaf Venture Partners, L.L.C.

Q1 2018 Holdings

Filed 2018-05-15 | 14 holdings | $185.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Deciphera Pharmaceuticals Inc(DCPHEUR)COM24344T101$82.2K4,104,14044.4%
Crispr Therapeutics AG(CRSP)NAMEN AKTH17182108$27.2K595,64214.7%
Wave Life Sciences LTD(WVE)SHSY95308105$18.4K458,2599.9%
Obseva SACOMH5861P103$12.0K890,5016.5%
Oxford Immunotec Global PLCORD SHSG6855A103$10.6K852,4975.7%
Sierra Oncology IncCOM82640U107$10.4K5,020,4465.6%
Unum Therapeutics IncCOM903214104$6.1K550,0003.3%
Affimed N VCOMN01045108$4.2K2,250,0002.2%
Reshape Lifesciences IncCOM761123108$3.8K2,600,9002.0%
Trillium Therapeutics IncCOM NEW89620X506$2.9K404,1591.6%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$2.8K964,5201.5%
Edge Therapeutics IncCOM279870109$2.8K2,344,8681.5%
Marinus Pharmaceuticals IncCOM56854Q101$1.3K342,5500.7%
Dermira Inc(DERMEUR)COM24983L104$48861,1090.3%